Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deakin

Showing results (961-970 of 1,228) with videos related to

Pageof 123
Sort By:
Journal of Psychopharmacology (Oxford, England)|September 5, 2024
Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatinImran B Chaudhry, Muhammad Omair Husain, Ameer B Khoso, et al.
Multiple Sclerosis and Related Disorders|February 4, 2026
Incident and prevalent peripartum mental illness in mothers with multiple sclerosis and other chronic diseases in SwedenRuth Ann Marrie, Colleen J Maxwell, James M Bolton, et al.
Plant Phenomics (Washington, D.C.)|December 27, 2023
The Dissection of Nitrogen Response Traits Using Drone Phenotyping and Dynamic Phenotypic Analysis to Explore N Responsiveness and Associated Genetic Loci in WheatGuohui Ding, Liyan Shen, Jie Dai, et al.
Schizophrenia Research|March 5, 2021
Peripheral immune markers and antipsychotic non-response in psychosisDaniela Enache, Naghmeh Nikkheslat, Dina Fathalla, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Olanzapine for recurrent aggression in a patient with temporal lobe epilepsy who had temporal lobectomyJaime E C Hallak, Serdar M Dursun, Ricardo Guarnieri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1994
Weekly VAPEC-B chemotherapy for high grade non-Hodgkin's lymphoma: results of treatment in 184 patientsJ A Radford, J S Whelan, A Z Rohatiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's diseaseJ A Radford, D Crowther, A Z Rohatiner, et al.
Neurology and Therapy|June 19, 2025
Impact of Early Antipsychotic Prescription Choice on Weight Gain in the First 5 Years of Psychotic Illness: a Retrospective Cohort StudyAdrian Heald, George Tilston, John Julian Warner-Levy, et al.
Pharmacogenetics|November 3, 2001
Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancerD E Bamber, A A Fryer, R C Strange, et al.
Neuropsychiatric Disease and Treatment|December 30, 2016
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trialMuhammad I Husain, Imran B Chaudhry, Munir M Hamirani, et al.
Pageof 123

Showing results (961-970 of 1,228) with videos related to

Sort By:
Pageof 123
Journal of Psychopharmacology (Oxford, England)|September 5, 2024
Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatinImran B Chaudhry, Muhammad Omair Husain, Ameer B Khoso, et al.
Multiple Sclerosis and Related Disorders|February 4, 2026
Incident and prevalent peripartum mental illness in mothers with multiple sclerosis and other chronic diseases in SwedenRuth Ann Marrie, Colleen J Maxwell, James M Bolton, et al.
Plant Phenomics (Washington, D.C.)|December 27, 2023
The Dissection of Nitrogen Response Traits Using Drone Phenotyping and Dynamic Phenotypic Analysis to Explore N Responsiveness and Associated Genetic Loci in WheatGuohui Ding, Liyan Shen, Jie Dai, et al.
Schizophrenia Research|March 5, 2021
Peripheral immune markers and antipsychotic non-response in psychosisDaniela Enache, Naghmeh Nikkheslat, Dina Fathalla, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Olanzapine for recurrent aggression in a patient with temporal lobe epilepsy who had temporal lobectomyJaime E C Hallak, Serdar M Dursun, Ricardo Guarnieri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1994
Weekly VAPEC-B chemotherapy for high grade non-Hodgkin's lymphoma: results of treatment in 184 patientsJ A Radford, J S Whelan, A Z Rohatiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's diseaseJ A Radford, D Crowther, A Z Rohatiner, et al.
Neurology and Therapy|June 19, 2025
Impact of Early Antipsychotic Prescription Choice on Weight Gain in the First 5 Years of Psychotic Illness: a Retrospective Cohort StudyAdrian Heald, George Tilston, John Julian Warner-Levy, et al.
Pharmacogenetics|November 3, 2001
Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancerD E Bamber, A A Fryer, R C Strange, et al.
Neuropsychiatric Disease and Treatment|December 30, 2016
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trialMuhammad I Husain, Imran B Chaudhry, Munir M Hamirani, et al.
Pageof 123